September 11, 2019
Nutrasource Pharmaceutical and Nutraceutical Services (Nutrasource), a global full-service contract research organization (CRO), is pleased to announce the establishment of an office in North Bethesda, MD. This location is strategic based on proximity to a series of major FDA (U.S. Food & Drug Administration) offices. The office will be managed by Kara Lewis, PhD who recently joined the Nutrasource team as Director of Scientific Affairs, GRAS Associates.
“Given our daily and positive interactions with FDA on various fronts on behalf of our clients, it made perfect strategic sense to position our new US office location in proximity to so many key FDA offices and facilities,” said William Rowe, President and CEO of Nutrasource. “This move is part of our continued commitment to serve our customers while viewing government agencies as allies in product development and market access. We look forward to an increased in person presence by way of this change for all of our stakeholders.”
Brad Wallace, COO of Nutrasource also adds, “The opening of a strategic office in North Bethesda, MD is another key step along the way to building Nutrasource into a global leader in the combined and emerging space of pharmaceutical and nutraceutical CRO services. This office compliments the addition of more than 30 leading project management, regulatory affairs, medical writing, data management and clinical scientists to our team combined with the doubling of our head office space and a state-of-the art clinical trials unit over the past year.”
The office address is as follows:
GRAS Associates LLC
11810 Grand Park Avenue, Suite 500
North Bethesda, MD, USA, 20852
Phone: 1-877-557-7722 Fax: 1-888-531-3466
About Nutrasource
Nutrasource is a premier CRO that brings unparalleled expertise in nutrition, regulatory affairs, and pharmaceutical science to help clients achieve compliance and gain market entry for health products globally. With nearly 20 years' experience across the entire product spectrum from foods and supplements to pharmaceuticals, Nutrasource provides vertically-integrated solutions and unmatched scientific acumen in the pharmaceutical and nutraceutical industries to design and execute clinical trials as well as develop regulatory strategies that provide a unique advantage in product commercialization. No other CRO has the combination of personnel, with the breadth and depth of experience in both pharmaceutical development and natural health products, providing the leadership needed to launch products with strong science and regulatory confidence – from concept to claim. www.nutrasource.ca
In addition to GRAS Associates LLC, the Nutrasource family of brands also includes a series of consumer-facing health product certification programs such as IFOS (International Fish Oil Standards Program), IGEN (International Genetically Modified Organism Evaluation and Notification Program), IPRO (International Probiotic Standards Program), and newly launched ICAP (International Cannabinoid Analysis Program).
For more information, please contact:
William Rowe, President and CEO, Nutrasource